Skip to content

Sample Page

Author: Biovica International

Posted Date:

July 16, 2026

Biovica Expands Japanese Patent Protection in Immuno-Oncology

Biovica International

July 16, 2026
Biovica Receives Ninth Work Order From a Leading Global Pharmaceutical Customer

Biovica International

July 14, 2026
Correction: Biovica appoints Maria Ekdahl as new Chief Financial Officer

Biovica International

July 7, 2026
Biovica Appoints Maria Ekdahl as New Chief Financial Officer

Biovica International

July 7, 2026
Biovica Expands Master Services Agreement with a Current Customer, a Leading Global Pharmaceutical Company, to Support Next-Generation Oncology Development

Biovica International

July 7, 2026
Biovica Granted Japanese Patent for Immuno-Oncology

Biovica International

July 1, 2026
Correction: Biovica Refocuses US Commercial Strategy and Terminates Agreement with Tempus AI

Biovica International

June 30, 2026
Biovica Refocuses US Commercial Strategy and Terminates Agreement with Tempus AI

Biovica International

June 30, 2026
Biovica International AB – Annual Report for The Financial Year 2025/2026 Published

Biovica International

June 30, 2026
Year-End Report 2025-2026

Biovica International

June 17, 2026

1 2 3